-
1
-
-
0037012341
-
Disaggregating the effects of race and poverty on breast cancer outcomes
-
Brawley OW: Disaggregating the effects of race and poverty on breast cancer outcomes. J Natl Cancer Inst 94:471-473, 2002
-
(2002)
J Natl Cancer Inst
, vol.94
, pp. 471-473
-
-
Brawley, O.W.1
-
2
-
-
1942440376
-
Poverty, culture, and social injustice: Determinants of cancer disparities
-
Freeman HP: Poverty, culture, and social injustice: Determinants of cancer disparities. CA Cancer J Clin 54:72-77, 2004
-
(2004)
CA Cancer J Clin
, vol.54
, pp. 72-77
-
-
Freeman, H.P.1
-
3
-
-
0028217282
-
Tumor biologic factors and breast cancer prognosis among White, Hispanic, and Black women in the United States
-
Elledge RM, Clark GM, Chamness GC, et al: Tumor biologic factors and breast cancer prognosis among White, Hispanic, and Black women in the United States. J Natl Cancer Inst 86:705-712, 1994
-
(1994)
J Natl Cancer Inst
, vol.86
, pp. 705-712
-
-
Elledge, R.M.1
Clark, G.M.2
Chamness, G.C.3
-
4
-
-
1942472485
-
Cancer disparities by race/ethnicity and socioeconomic status
-
Ward E, Jemal A, Cokkinides V, et al: Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 54:78-93, 2004
-
(2004)
CA Cancer J Clin
, vol.54
, pp. 78-93
-
-
Ward, E.1
Jemal, A.2
Cokkinides, V.3
-
5
-
-
0027183973
-
The relation between health insurance coverage and clinical outcomes among women with breast cancer
-
Ayanian JZ, Kohler BA, Abe T, et al: The relation between health insurance coverage and clinical outcomes among women with breast cancer. N Engl J Med 329:326-331, 1993
-
(1993)
N Engl J Med
, vol.329
, pp. 326-331
-
-
Ayanian, J.Z.1
Kohler, B.A.2
Abe, T.3
-
6
-
-
0020772177
-
The estimation of age, period, and cohort effects for vital rates
-
Holford TR: The estimation of age, period, and cohort effects for vital rates. Biometrics 39:311-324, 1983
-
(1983)
Biometrics
, vol.39
, pp. 311-324
-
-
Holford, T.R.1
-
7
-
-
0034571799
-
Age-period-cohort analyses of breast-, ovarian-, endometrial- and cervical-cancer mortality rates for Caucasian women in the USA
-
Tarone RE, Chu KC: Age-period-cohort analyses of breast-, ovarian-, endometrial- and cervical-cancer mortality rates for Caucasian women in the USA. J Epidemiol Biostat 5:221-231, 2000
-
(2000)
J Epidemiol Biostat
, vol.5
, pp. 221-231
-
-
Tarone, R.E.1
Chu, K.C.2
-
8
-
-
0030999351
-
Recent trends in breast cancer mortality among White and Black women
-
Chevarley F, White E: Recent trends in breast cancer mortality among White and Black women. Am J Public Health 87:775-781, 1997
-
(1997)
Am J Public Health
, vol.87
, pp. 775-781
-
-
Chevarley, F.1
White, E.2
-
9
-
-
0033227675
-
Breast cancer trends of black women compared with white women
-
Chu KC, Tarone RE, Brawley OW: Breast cancer trends of black women compared with white women. Arch Fam Med 8:521-528, 1999
-
(1999)
Arch Fam Med
, vol.8
, pp. 521-528
-
-
Chu, K.C.1
Tarone, R.E.2
Brawley, O.W.3
-
10
-
-
3543064179
-
-
Ries LAG, Eisner MP, Kosary CL, et al eds, Bethesda, MD, National Cancer Institute
-
Ries LAG, Eisner MP, Kosary CL, et al (eds). SEER Cancer Statistics Review, 1975-2001, Bethesda, MD, National Cancer Institute. http://seer.cancer. gov/csr/1975-2001
-
(1975)
SEER Cancer Statistics Review
-
-
-
11
-
-
84878016906
-
-
Surveillance Research Program:, Bethesda, MD, National Cancer Institute
-
Surveillance Research Program: SEER*Stat Software. Bethesda, MD, National Cancer Institute. http://seer.cancer.gov/
-
SEER*Stat Software
-
-
-
12
-
-
34247533796
-
-
National Cancer Institute: SEER*Stat version 5.3.1. Bethesda, MD, National Cancer Institute
-
National Cancer Institute: SEER*Stat version 5.3.1. Bethesda, MD, National Cancer Institute. http://www.seer.cancer.gov/seerstat
-
-
-
-
14
-
-
0037394316
-
Why is breast cancer mortality declining?
-
Jatoi I, Miller AB: Why is breast cancer mortality declining? Lancet Oncol 4:251-254, 2003
-
(2003)
Lancet Oncol
, vol.4
, pp. 251-254
-
-
Jatoi, I.1
Miller, A.B.2
-
15
-
-
0029903615
-
Recent trends in U.S. breast cancer incidence, survival, and mortality rates
-
Chu KC, Tarone RE, Kessler LG, et al: Recent trends in U.S. breast cancer incidence, survival, and mortality rates. J Natl Cancer Inst 88:1571-1579, 1996
-
(1996)
J Natl Cancer Inst
, vol.88
, pp. 1571-1579
-
-
Chu, K.C.1
Tarone, R.E.2
Kessler, L.G.3
-
16
-
-
0142054702
-
Mammography screening: Are women really given informed consent?
-
Baines CJ: Mammography screening: Are women really given informed consent? J Natl Cancer Inst 95:1508-1511, 2003
-
(2003)
J Natl Cancer Inst
, vol.95
, pp. 1508-1511
-
-
Baines, C.J.1
-
17
-
-
0031311242
-
Variation in the effectiveness of breast screening by year of follow-up
-
Cox B: Variation in the effectiveness of breast screening by year of follow-up. J Natl Cancer Inst Monogr 22:69-72, 1997
-
(1997)
J Natl Cancer Inst Monogr
, vol.22
, pp. 69-72
-
-
Cox, B.1
-
18
-
-
12844250453
-
Menopausal status dependence of early mortality reduction due to diagnosis of smaller breast cancers (T1 v T2-T3): Relevance to screening
-
Demicheli R, Bonadonna G, Hrushesky WJM, et al: Menopausal status dependence of early mortality reduction due to diagnosis of smaller breast cancers (T1 v T2-T3): Relevance to screening. J Clin Oncol 22:102-107, 2004
-
(2004)
J Clin Oncol
, vol.22
, pp. 102-107
-
-
Demicheli, R.1
Bonadonna, G.2
Hrushesky, W.J.M.3
-
19
-
-
17644404753
-
Distinct breast cancer incidence and prognostic patterns in the NCI's SEER program: Suggesting a possible link between etiology and outcome
-
Anderson WF, Jatoi I, Devesa SS: Distinct breast cancer incidence and prognostic patterns in the NCI's SEER program: Suggesting a possible link between etiology and outcome. Breast Cancer Res Treat 90:127-137, 2005
-
(2005)
Breast Cancer Res Treat
, vol.90
, pp. 127-137
-
-
Anderson, W.F.1
Jatoi, I.2
Devesa, S.S.3
-
20
-
-
14344264034
-
Does surgery unfavorably perturb the "natural history" of early breast cancer by accelerating the appearance of distant metastases?
-
Baum M, Demicheli R, Hurshesky W, et al: Does surgery unfavorably perturb the "natural history" of early breast cancer by accelerating the appearance of distant metastases? Eur J Cancer 41:508-515, 2005
-
(2005)
Eur J Cancer
, vol.41
, pp. 508-515
-
-
Baum, M.1
Demicheli, R.2
Hurshesky, W.3
-
21
-
-
0028817211
-
Efficacy of screening mammography: A meta-analysis
-
Kerlikowske K, Grady D, Rubin SM, et al: Efficacy of screening mammography: A meta-analysis. JAMA 273:149-154, 1995
-
(1995)
JAMA
, vol.273
, pp. 149-154
-
-
Kerlikowske, K.1
Grady, D.2
Rubin, S.M.3
-
22
-
-
0031316208
-
Benefit of screening mammography in women aged 40-49: A new meta-analysis of randomized controlled trials
-
Hendrick RE, Smith RA, Rutledge JH III, et al: Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr 22:87-92, 1997
-
(1997)
J Natl Cancer Inst Monogr
, vol.22
, pp. 87-92
-
-
Hendrick, R.E.1
Smith, R.A.2
Rutledge III, J.H.3
-
23
-
-
0031324272
-
Efficacy of screening mammography among women aged 40 to 49 years and 50 to 69 years: Comparison of relative and absolute benefit
-
Kerlikowske K: Efficacy of screening mammography among women aged 40 to 49 years and 50 to 69 years: Comparison of relative and absolute benefit. J Natl Cancer Inst Monogr 22:79-86, 1997
-
(1997)
J Natl Cancer Inst Monogr
, vol.22
, pp. 79-86
-
-
Kerlikowske, K.1
-
24
-
-
34247469855
-
Delayed benefit of mammography screening in premenopausal women
-
Jatoi I, Soballe PW, Anderson WF: Delayed benefit of mammography screening in premenopausal women. J Clin Oncol 23:4860, 2004
-
(2004)
J Clin Oncol
, vol.23
, pp. 4860
-
-
Jatoi, I.1
Soballe, P.W.2
Anderson, W.F.3
-
25
-
-
0032537396
-
Tamoxifen for early breast cancer: An overview of the randomized trials
-
Early Breast Cancer Trialists' Collaborative Group
-
Early Breast Cancer Trialists' Collaborative Group: Tamoxifen for early breast cancer: An overview of the randomized trials. Lancet 351:1451-1467, 1998
-
(1998)
Lancet
, vol.351
, pp. 1451-1467
-
-
-
26
-
-
0032547564
-
Polychemotherapy for early breast cancer: An overview of the randomized trials
-
Early Breast Cancer Trialsists Collaborative Group
-
Early Breast Cancer Trialsists Collaborative Group: Polychemotherapy for early breast cancer: An overview of the randomized trials. Lancet 352:930-942, 1998
-
(1998)
Lancet
, vol.352
, pp. 930-942
-
-
-
27
-
-
0026595133
-
Systemic treatment of early breast cancer by hormonal, cytotoxic, and immune therapy. 133 randomized trials, involving 31,000 recurrences and 24,000 deaths among 75,000 women
-
Early Breast Cancer Trialists' Collaborative Group
-
Early Breast Cancer Trialists' Collaborative Group: Systemic treatment of early breast cancer by hormonal, cytotoxic, and immune therapy. 133 randomized trials, involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 339:71-85, 1992
-
(1992)
Lancet
, vol.339
, pp. 71-85
-
-
-
28
-
-
0037032510
-
Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999
-
Mariotto A, Feuer EJ, Harlan LC, et al: Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999. J Natl Cancer Inst 94:1626-1634, 2002
-
(2002)
J Natl Cancer Inst
, vol.94
, pp. 1626-1634
-
-
Mariotto, A.1
Feuer, E.J.2
Harlan, L.C.3
-
29
-
-
0037012339
-
Race, socioeconomic status, and breast cancer treatment and survival
-
Bradley CJ, Given CW, Roberts C: Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst 94:90-96, 2002
-
(2002)
J Natl Cancer Inst
, vol.94
, pp. 90-96
-
-
Bradley, C.J.1
Given, C.W.2
Roberts, C.3
-
30
-
-
0346495955
-
Trends in breast cancer by race and ethnicity
-
Ghafoor A, Jemal A, Ward E, et al: Trends in breast cancer by race and ethnicity. CA Cancer J Clin 53:342-355, 2003
-
(2003)
CA Cancer J Clin
, vol.53
, pp. 342-355
-
-
Ghafoor, A.1
Jemal, A.2
Ward, E.3
-
31
-
-
0041736242
-
Racial disparity in the dose and dose intensity of breast cancer adjuvant chemotherapy
-
Griggs JJ, Sorbero MES, Stark AT, et al: Racial disparity in the dose and dose intensity of breast cancer adjuvant chemotherapy. Breast Cancer Res Treat 81:21-31, 2003
-
(2003)
Breast Cancer Res Treat
, vol.81
, pp. 21-31
-
-
Griggs, J.J.1
Sorbero, M.E.S.2
Stark, A.T.3
-
32
-
-
0041887167
-
Widening disparity in survival between White and African-American patients with breast carcinoma treated in the U.S. Department of Defense Healthcare System
-
Jatoi I, Becher H, Leake CR: Widening disparity in survival between White and African-American patients with breast carcinoma treated in the U.S. Department of Defense Healthcare System. Cancer 98:894-899, 2003
-
(2003)
Cancer
, vol.98
, pp. 894-899
-
-
Jatoi, I.1
Becher, H.2
Leake, C.R.3
-
33
-
-
20144372095
-
Ethnicity and breast cancer: Factors influencing differences in incidence and outcome
-
Chlebowski RT, Chen A, Anderson GL, et al: Ethnicity and breast cancer: Factors influencing differences in incidence and outcome. J Natl Cancer Inst 97:439-448, 2005
-
(2005)
J Natl Cancer Inst
, vol.97
, pp. 439-448
-
-
Chlebowski, R.T.1
Chen, A.2
Anderson, G.L.3
|